United States · Pre-seed startup

Who invested in Resilient Lifescience

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Kraised across 1 round since 2023, from 1 source

Latest round
Pre-seed, $50KDec 2023
Investors
3
See who backed them

The rounds

  1. Dec 2023

Founders and team

From Resilient Lifescience's own website and the SEC filings it signed: 1 founder, 4 on the team.

Brad HoldenCo-founder and CEO
  • Bradford HoldenChief Executive Officer and Treasureri
  • Charlie ProctorCTO and Cofounder
  • Kevin ChouMechanical Design Engineer
  • Charles ProctorSecretaryi

Everyone who backed them

Innovation WorksGovernment1round
Tau VenturesVC firm1round
Richard King Mellon FoundationPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Resilient Lifescience

Who invested in Resilient Lifescience?

Resilient Lifescience's investors include Innovation Works, Tau Ventures and Richard King Mellon Foundation.

How much has Resilient Lifescience raised?

Resilient Lifescience has raised $50K across 1 round since 2023.

When did Resilient Lifescience last raise?

Resilient Lifescience's most recent round was a Pre-seed of $50K in Dec 2023.

What was Resilient Lifescience's biggest round?

Its most recent round, $50K in Dec 2023, is also its largest on record.

Who backed Resilient Lifescience first?

Resilient Lifescience's first round on record, in Dec 2023, was backed by Innovation Works, Tau Ventures and Richard King Mellon Foundation.

What stage is Resilient Lifescience at?

Resilient Lifescience's latest named round is a Pre-seed, in Dec 2023.

Where is Resilient Lifescience based?

Resilient Lifescience is based in the United States.

Companies like Resilient Lifescience

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.